Document Detail


Streptokinase use in children undergoing cardiac catheterization.
MedLine Citation:
PMID:  2600615     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The development of cardiac catheterization procedures in the pediatric population has evolved from diagnostic in nature to present day advanced technology and interventions. A complication of vessel occlusion secondary to large catheters, length of procedures, and patient size requires immediate intervention. The advent of thrombolytic agents has provided a highly effective mode of treatment in restoring circulation. The use of streptokinase, its efficacy, side effects, and nursing management are discussed.
Authors:
S J Reidy; P A O'Hara; P O'Brien
Related Documents :
6661925 - Thrombolytic therapy of acute myocardial infarction.
12635885 - Alteration of myocardial mechanics in marginal magnesium deficiency.
8891805 - Magnesium therapy, fibrinolytic parameters and von willebrand factor in acute myocardia...
53055 - Nitroglycerin and premature ventricular complexes in myocardial infarction.
6156885 - Cardiac arrhythmias: mechanisms and management: ii. electrocardiographic analysis of ca...
10442125 - Percutaneous balloon mitral valvotomy: initial experience in nairobi using a new multi-...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The Journal of cardiovascular nursing     Volume:  4     ISSN:  0889-4655     ISO Abbreviation:  J Cardiovasc Nurs     Publication Date:  1989 Nov 
Date Detail:
Created Date:  1990-02-08     Completed Date:  1990-02-08     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  8703516     Medline TA:  J Cardiovasc Nurs     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  46-56     Citation Subset:  N    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Child
Heart Catheterization / adverse effects*
Humans
Patient Care Planning
Streptokinase / adverse effects,  therapeutic use*
Thrombosis / drug therapy*,  etiology,  nursing
Chemical
Reg. No./Substance:
EC 3.4.-/Streptokinase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Implementing a flow sheet for thrombolytic therapy.
Next Document:  Competency-based education in thrombolytic therapy: a modular approach.